Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Cancer Research Institute
Apr 8, 2024, 15:49 |
Insight
Paolo Tarantino: The TRAIN3 trial of MRI-guided TCHP is out in The Lancet Oncology
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, recently shared on X: "The TRAIN3…
Apr 8, 2024, 15:38 |
Societies
Vivek Subbiah: Terrific start at the AACR Grant Writing Workshop
Vivek Subbiah recently posted on X: "AACR is off to a terrific start. Postdoctoral fellows…
Apr 8, 2024, 15:34 |
Blog
Roupen Odabashian: If nurses are being replaced today what does tomorrow hold?
Roupen Odabashian shared on LinkedIn: "If nurses are being replaced today what does tomorrow hold?…
Apr 8, 2024, 15:24 |
Insight
Amalya Sargsyan: Fantastic paper out in AACR Journals on the role of TME in NSCLC
Amalya Sargsyan, Medical Oncologist at Yeolyan Oncology and Hematology Center, shared on LinkedIn: "Is targeting…
Apr 8, 2024, 15:17 |
Blog
Petros Grivas: Can’t wait to join Paolo Tarantino and Helena Yu to review ADCs across solid tumors
Petros Grivas, Associate Professor at the University of Washington, recently shared a post by Paolo…
Apr 8, 2024, 11:46 |
Blog
Elad Sharon: Listening to my mentee, Rafeh Naqash, present some incredible data at the SWOG plenary!
Elad Sharon, Clinical and Translational Director at Dana-Farber Cancer Institute, shared a post on X: "Listening to…
Apr 8, 2024, 07:46 |
Positive
Vivek Subbiah: OUR ACTION LEADER who keeps me inspired! Incredibly proud!
Vivek Subbiah recently shared on his LinkedIn page: "Before heading to the American Association for…
Apr 8, 2024, 03:54 |
Drugs
Paolo Tarantino: Trastuzumab deruxtecan is now FDA approved for ANY treatment-refractory HER2+ solid tumor
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 8, 2024, 03:45 |
Drugs
Vivek Subbiah: First ADC tissue agnostic drug approved!
Quoting Vivek Subbiah's post on LinkedIn: "Just in time for American Association for Cancer Research…
Apr 7, 2024, 04:00 |
Societies
Ishwaria Subbiah: Grateful to the ASCO for giving volunteers like me such meaningful opportunities to come together and give back to oncology
Ishwaria Subbiah shared a post by American Society of Clinical Oncology (ASCO) on LinkedIn, adding:…
279
280
281
282
283
All:
3218
Posts:
2801 - 2810
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube